We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Cancer Detected Earlier and Faster with New Imaging Technology

By MedImaging staff writers
Posted on 08 Apr 2008
Clinicians may soon be able to detect early stages of colon cancer without a biopsy, using a new imaging technique.

This imaging technology, developed by researchers from the Stanford University School of Medicine (Stanford, CA, USA), is one of many new ways of detecting cancers in the body in real time, according to Christopher Contag, Ph.D., Stanford associate professor of pediatrics and of microbiology and of immunology, who led the study. More...
Dr. Contag reported that he hoped it might be one of the first to be used routinely for early detection of cancer.

"Detecting colon cancers is just the first step,” said Dr. Contag. He predicted similar techniques would eventually be able to find a wide range of cancers, monitor cancer treatment, and deliver chemotherapies directly to cancerous cells in the colon, stomach, mouth, and skin. The study was published online March 16, 2008, issue of the journal Nature Medicine.

Colon cancer is the third most common cancer in men and women, with approximately 150,000 people diagnosed each year in the United States. Although colonoscopy is not perfect, it is currently the best way of finding colon cancers when they are still at the most treatable stage.

The trick to detecting cancer without a biopsy is to find a way of seeing which cells are cancerous while they are still in the body. That is what Dr. Contag and his group succeeded in doing. The group found a short protein that adheres to colon cells in the early stages of cancer. Before screening a person, they spray that short protein attached to a fluorescent beacon into the colon. The protein then attaches to any cancerous cells and creates an easily visible fluorescent patch.

Not only did the researchers see fluorescent patches, they could make out the individual cancerous cells. That fine resolution could allow clinicians to identify the earliest possible tumors. According to Dr. Contag, it could also become a useful research tool for studying the small number of cancer stem cells that are thought to establish the eventual tumor.

In the initial trial with 15 patients, the technique detected 82% of the polyps that were considered cancerous by a pathologist. Dr. Contag reported that the next step is to work with some of the additional small proteins they have found that also attach to cancerous cells. He thinks that a combination of those proteins will make the technique highly accurate.

Once the screen is ready for widespread use, it could bring effective cancer detection to people in remote locations who otherwise do not have access to pathology labs. "A doctor could send a video in real time via the Internet to someone trained to analyze the living cell images,” Dr. Contag said. This could help people begin the appropriate therapy when the cancer is still at an early stage.

Dr. Contag believes this technique, developed in part through the cancer-imaging program at the Stanford Cancer Center, could also be adapted to detect cancers in the mouth, esophagus, and the stomach. Moreover, real-time screening could be used as a way of assessing whether a chemotherapy regimen is working.


Related Links:
Stanford University School of Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.